Firm Recognized as Top-Tier Manager Yet Again
In a glittering ceremony held on May 22, 2025, at the Gesellschaftshaus Palmengarten in Frankfurt, Germany, Vetter Pharma-Fertigung GmbH & Co. KG was honoured with the prestigious Best Managed Companies Award for the sixth time in a row. The award recognises Vetter for its strategic and sustainable corporate management, making it a standout in the global pharmaceutical industry.
With a rich history spanning 75 years, Vetter is a family-owned company that has established itself as an industry pioneer in sustainability and a socially and ethically responsible corporate citizen. The company's operations extend across Asia-Pacific markets, including Japan, China, South Korea, and Singapore, and it maintains production facilities in Germany, Austria, and the US, with its headquarters in Ravensburg, Germany.
The Best Managed Companies Award is a testament to Vetter's commitment to excellence in several critical areas. Companies like Vetter, which have been recognised by the award, demonstrate strategic excellence, strong corporate culture, innovation capabilities, and robust governance, including comprehensive Environmental, Social, and Governance (ESG) strategies and transparent reporting.
The evaluation process for the award is rigorous and comprehensive, focusing on strategy, capabilities and innovation, culture and commitment, and governance and financial performance. Operational excellence, commitment to ESG principles, and the company's ability to innovate and maintain a competitive edge are assessed through an independent and rigorous process, benchmarking management skills and practices against a global community of top private companies.
In 2024, Vetter achieved significant growth, with sales reaching 1.1 billion euros, a 11% increase from the previous year. This growth is a testament to the company's ability to execute strategic plans effectively and demonstrate clear business direction and innovation.
Renowned pharma and biotech companies rely on Vetter's experience, quality, modern technologies, reliability, and commitment. Vetter supplies medicines to patients worldwide, many of which are vital, and offers services from drug product development through clinical and commercial filling to various assembly and packaging services for vials, syringes, and cartridges.
The company is also focusing on digitization of production processes, AI, human-machine interaction, cloud, and cyber security, demonstrating its commitment to staying at the forefront of technological advancements. Vetter has invested 269 million euros in the expansion and modernization of its sites in Germany, Austria, and the US in 2024.
In addition to its business success, Vetter has placed a strategic focus on sustainability for many years. The company published its fourth comprehensive sustainability report earlier this year, showcasing its commitment to environmental responsibility, social equity, and ethical governance. Vetter is a member of the UN Global Compact and Science Based Target initiative (SBTi) and received gold status in the EcoVadis ranking.
Vetter collaborates with customers to develop prefilled drug-delivery systems and improve patient safety, comfort, and compliance. Markus Kirchner, Vetter's corporate spokesperson, can be reached at +49 (0)751-3700-3729 or [email protected] for further information about the company. More information about Vetter can be found on their website www.vetter-pharma.com and LinkedIn. As of 2025, Vetter employs 7,000 global employees.
- Vetter Pharma-Fertigung GmbH & Co. KG, with its focus on digital transformation, invests in advancements like cloud, AI, and human-machine interaction, demonstrating a commitment to staying at the forefront of technological progress.
- In 2025, Vetter's strategic emphasis on ESG (Environmental, Social, and Governance) principles earned them gold status in the EcoVadis ranking and membership in the UN Global Compact and Science Based Target initiative (SBTi).
- The digitization of production processes at Vetter includes a focus on cyber security, which is crucial for the protection of sensitive financial, business, and client data in the pharmaceutical industry.
- Vetter's collaborative efforts with customers extend to improving patient compliance through the development of prefilled drug-delivery systems, illustrating a commitment to enhancing patient safety and comfort.
